Amgen Announces Webcast of 2009 Second Quarter Financial Results
24 July 2009 - 3:27AM
PR Newswire (US)
THOUSAND OAKS, Calif., July 23 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) today announced that it plans to report its second
quarter financial results on Monday, July 27, 2009 after the close
of the financial markets. The announcement will be followed by a
conference call with the investment community at 2 p.m. Pacific
Time. Participating in the call from Amgen will be Kevin Sharer,
chairman and chief executive officer, and other members of Amgen's
senior management team. Live audio of the conference call will be
simultaneously broadcast over the Internet and will be available to
members of the news media, investors and the general public. The
conference call, including the question and answer session, is
expected to last approximately one hour. The webcast of the
conference, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's Web site,
http://www.amgen.com/, under Investors. Information regarding
presentation times, webcast availability, and webcast links are
noted on Amgen's Investor Relations Events Calendar. The webcast
will be archived and available for replay 72 hours after the event.
About Amgen Amgen discovers, develops, manufactures and delivers
innovative human therapeutics. A biotechnology pioneer since 1980,
Amgen was one of the first companies to realize the new science's
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid
arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to
advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk,
805-447-4613 (media) Arvind Sood, 805-447-1060 (investors) (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, David
Polk, +1-805-447-4613, or investors, Arvind Sood, +1-805-447-1060,
both of Amgen, Thousand Oaks Web Site: http://www.amgen.com/
Copyright